Skip to content

Finance AlphaSpace


HOW CAN WE HELP YOU?
Welcome to the Yahoo Finance AlphaSpace Feedback Forum, the place where you can make product suggestions and provide feedback. We’re always trying to improve our products and use your feedback to make positive changes.

OUR COMPANY
Yahoo Finance is operated by Yahoo Inc. In 2021, Apollo Global Management, Inc. (NYSE: APO) acquired Yahoo (formerly Verizon Media, itself formerly known as Oath) from Verizon. Yahoo operates as a standalone company under Apollo.

SHARE FEEDBACK
Note: This forum is not monitored for support-related issues, so if you need help with a problem or have a question, please visit our Help Site where you can Contact Us.

The Yahoo product feedback forum now requires a valid Yahoo ID and password to participate. If you do not have a Yahoo ID or the password to your Yahoo ID, please sign-up for a new account.

If you have a valid Yahoo ID and password, follow these steps if you would like to remove your posts, comments, votes, and/or profile from the Yahoo product feedback forum.


37 results found

  1. AlphaSpace for masses

    AlphaSpace could enable masses to invest better if it evolves toward a FactSet-level biopharma research experience — with analyst-level estimates, product revenue breakdowns, specialist fund tracking, and pipeline catalyst monitoring built into a single workflow

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  2. Estimates

    Individual analyst names with their specific EPS, revenue, R&D, and SG&A estimates broken out in the consensus estimates panel 2.C onsensus estimates panel should include analyst averages for R&D and SG&A line items, not just EPS and revenue — especially critical for biopharma where R&D spend is a primary value driver

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  3. Product/asset-level revenue breakdown panel

    Product/asset-level revenue breakdown panel — both reported actuals and analyst consensus estimates per drug — critical for biopharma where a single asset like Keytruda or Ozempic can drive the majority of company value

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  4. Institutional investors/shareholders panel

    Institutional investors/shareholders panel — live panel showing top holders, ownership percentage, and quarter-over-quarter changes for a focused ticker

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  5. Fund directory panel

    Fund directory panel — curated list of specialist biopharma/healthcare investors with their latest 13F summary, AUM in biopharma, and top holdings, clickable to drill into their full position list

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  6. 13F investor panel

    13F investor panel — track position changes from named specialist biopharma funds (RA Capital, Baker Brothers, ARK Invest, Perceptive Advisors, Orbimed) with their latest filings, new positions, additions, reductions, and exits, filtered by watchlist tickers

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  7. SEC filings panel

    SEC filings panel — dedicated panel surfacing 10-K, 10-Q, and 8-K filings for a focused ticker directly in the view

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  8. SEC filings panel

    SEC filings panel — dedicated panel surfacing 10-K, 10-Q, and 8-K filings for a focused ticker directly in the view

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  9. Short interest

    Short interest panel showing short interest, days to cover, and short interest change over time for individual tickers

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  10. Customizable watchlist column order

    Customizable watchlist column order — ability to drag and reorder columns (symbol, price, change, market cap, volume, etc.) to match your preferred workflow

    Minimize/collapse panel option — ability to collapse a panel to a title bar without removing it from the view, to reduce clutter while keeping the layout intact

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  11. Minimize/collapse panel option

    Minimize/collapse panel option — ability to collapse a panel to a title bar without removing it from the view, to reduce clutter while keeping the layout intact

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  12. Customizable watchlist columns

    Customizable watchlist columns — ability to add pre-market and post-market price, change, and volume as columns alongside regular trading hours data in the watchlist panel

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  13. Short interest data and graph and individual analyst estimates and ratings

    1. Individual analyst names with their specific EPS, revenue, R&D, and SG&A estimates broken out in the consensus estimates panel 2.C onsensus estimates panel should include analyst averages for R&D and SG&A line items, not just EPS and revenue — especially critical for biopharma where R&D spend is a primary value driver
    2. Product/asset-level revenue breakdown panel — both reported actuals and analyst consensus estimates per drug — critical for biopharma where a single asset like Keytruda or Ozempic can drive the majority of company value
    3. Short interest panel showing short interest, days to cover, and short interest change over time for…
    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  14. I cannot download S&P 500 Total Return data - but I can write a Python script and do so.

    Seriously, I am unable download the S&P 500 Total Return data (^SP500TR) from Yahoo Finance or AlphaSpace.

    That's ridiculous! I used to be able to do this is Yahoo Finance.

    I tried in AlphaSense. I can't do it. I asked customer service and was told it cannot be done, and was sent to a super lame data limitations page. That's a terrible response. A $500 a year product cannot do a simple request.

    Yet, I can get this data with a Python script --- for free! (See below)

    Why would anyone want to pay for AlphaSpace if you can't do…

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  15. Trendlines need to be saved per stock

    When I draw a trendline on a stock chart it carries over to the next stock I look at. I need to be able to anchor them to the specific stock I am creating it on or it looses its benefit, I can't use the trendlines to track how that stock is performing relative to its trendlines. I used your AI help and this is what it said:

    This is a known limitation of panel-based charting — annotations don't persist per-ticker across a shared chart. If you'd like to request per-ticker annotation saving as a feature, the Share feedback option…

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  16. Day Gainers Screener Refresh Rate is Too Slow for Active Trading Use

    The Day Gainers screener panel in AlphaSpace currently has a refresh cycle of 57+ minutes, which makes it effectively unusable for premarket and intraday momentum scanning. For a premium platform, this is a significant gap.

    What I need: Real-time or sub-minute refresh rates on screener panels — particularly Day Gainers, Most Actives, and any momentum-based screener used for active market monitoring.

    Why it matters: Premarket movers can spike and reverse within minutes. A screener that updates once per hour misses the entire move. Competing platforms refresh screeners every 5–15 seconds as a baseline. AlphaSpace should match or exceed that standard…

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  17. Better research

    Alphasense does not even realize how terrible it is. The ratings and analyst reports are garbage. No top-tier equity analysis with real analysis. Yahoo continues to broadcast bottom tier robo-research like Zacks and Insider Monkey. What a disappointment for a premium paid-product. This is just Yahoo Finance free version with a fancy interface. Lame. I can't even download historical prices of S&P500 total return data.

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  18. Multiple Stocks and Technical Analysis Table Download to Excel

    Need a table view for multiple stocks and their selected technical analysis. Currently this can be done for invidual stocks. It's very time consuming copying data. request CSV/Excel export for panel data.

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  19. Screeners not working as expected and it's really frustrating.

    Like if I select Morning 5-Star ratings, it says 87 results but shopws only 5, when I change the page settings from 25 to 50 then it says your session is expired. I triws login in a new browser Safari but still the same issue. Same happens when I add columns in my report. Pls help me to take the optimal usage of this.

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  20. Filter by Source

    I want to be able to filter which news sources show up on my feed. For example, I only want to see news from Yahoo Finance, Reuters, and Bloomberg.

    1st ranked

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    0 comments  ·  Admin →
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
← Previous 1
  • Don't see your idea?

Finance AlphaSpace

Categories